Pharma

Your Article Summary

See Latest Articles

Mylan Receives Tentative FDA Approval for Generic Version of Singulair
Mylan, 06/01/09

Mylan Inc. announced that it has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Montelukast Sodium Tablets, 10 mg. Montelukast Sodium Tablets are the generic version of Merck and Co.'s Singulair, which had total U.S. sales of approximately $2.6 billion for the 12 months ending March for the same strength, according to IMS Health. This product is indicated for asthma and allergy treatment.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09

Safety concerns slow new drug review and approval processes
Formulary , 12/02/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

 See all of Drug/Product Approvals